Program Outline
Topic: Emerging HER2-directed Therapeutic Agents in HER2 Low mBC
The journal club is meant to foster dynamic dialogue and clinical debate.
Oncology is an ever-evolving study of medicine. Many papers have helped shape up the stream of medicine.
Over the years we have stumbled over papers which have given us the opportunity to develop our understanding and improve.
Once a month we will organize the EIOC Journal Club, where these papers will be reviewed.
17 April, 2023 Journal Club
"Supported By"
Upcoming Events
The next EIOC Journal Club is scheduled to be held in the month of April 2023. The topic and Panelists will be announced later. Stay tuned!
View our Past Events
The EIOC Journal Club was organized on 06 March 2023, where a panel of 6 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early-Stage Breast Cancer
The EIOC Journal Club was organized on 28 February 2023, where a panel of 4 speakers discusses on current paper revolving around Management of HER2+ Metastatic Breast Cancer Patients
The EIOC Journal Club was organized on 22 February 2023, where a panel of 5 speakers discusses on current paper revolving around Management of HR+ HER2- mBC Patients
The EIOC Journal Club was organized on 13 February 2023, where a panel of 4 speakers discusses on current paper revolving around Current Treatment Paradigm for HER2+ Early BC & mBC
The EIOC Journal Club was organized on 19 December 2022, where a panel of 6 speakers discusses on current paper revolving around Integration of the Latest Evidence into the Management of Metastatic Triple Negative Breast Cancer.
The EIOC Journal Club was organized on 14 October 2022, where a panel of 11 speakers discusses on current paper revolving around Management of HER2 Low Breast Cancer
The EIOC Journal Club was organized on 08 July 2022, where a panel of 6 speakers discusses on current paper revolving around Highlights & Updates from ASCO: Key Abstracts & Presentations
The EIOC Journal Club was organized on 02 July 2022, where a panel of 6 speakers discusses on current paper revolving around Shifting Perspectives in HR+/HER2- Advanced Breast Cancer
The EIOC Journal Club was organized on 10 June 2022, where a panel of 6 speakers discusses on current paper revolving around Role of Immunotherapy in NSCLC
The EIOC Journal Club was organized on 27 May 2022, where a panel of 7 speakers discusses on current paper revolving around Making Precision Oncology the Standard of Care
The EIOC Journal Club was organized on 20 May 2022, where a panel of 6 speakers discusses on current paper revolving around Increasing Access to Breast Cancer Treatment through Biosimilars
The EIOC Journal Club was organized on 22 April 2022, where a panel of 5 speakers discusses on current paper revolving around High Risk Pre-Menopausal Hormonal +ve Early Stage Breast Cancer
The EIOC Journal Club was organized on 25 February 2022, where a panel of 9 speakers discusses on current paper revolving around Clinical Utility of ctDNA for CRC and Immunotherapy response monitoring
The sixth EIOC Journal Club was organized on 4 December 2021, where a panel of 11 speakers discusses on current paper revolving around Optimising Therapy in Hormone Receptor Positive Breast Cancer
The fifth EIOC Journal Club was organized on 28 August 2021, where a panel of 11 speakers discusses on current paper revolving around Deconstructing OlympiA and IO in early-stage TNBC : Is it time to change practice?
The fouth EIOC Journal Club was organized on 16 July 2021, where a panel of 8 speakers discusses on current paper revolving around Immunotherapy and Targeted Approaches for Gynae Malignancies
The third EIOC Journal Club was organized on 2 July 2021, where a panel of 10 speakers discusses on current paper revolving around “Hormone receptive positive Breast Cancer”
The second EIOC Journal Club was organized on 25 June 2021, where a panel of 10 speakers discusses on current paper revolving around Triple- Negative and HER2 positive Breast Cancer
The first EIOC Journal Club was organized on 21 May 2021, where a panel of 10 speakers discusses on current paper revolving around Genomic Testing, Ovarian Function Suppression, Hormone receptor positive HER2 – eBC.
Disclaimer :
This site does not recommend, endorse or promote any particular management approach, methodology or treating agents. The views expressed by various experts are their own.